Comparison of lovastatin and bezafibrate on lipoprotein(a) plasma levels in cardiac transplant recipients
1995; Elsevier BV; Volume: 75; Issue: 8 Linguagem: Inglês
10.1016/s0002-9149(99)80642-0
ISSN1879-1913
AutoresFrancisco Pérez‐Jiménez, Luis Hidalgo, José Luis Zambrana, José M. Arizón, J. Jiménez-Perepérez, Manuel Concha, A. Espino, Julia Blanco, Federico Vallés, José López‐Miranda,
Tópico(s)Viral Infections and Immunology Research
ResumoOur results suggest that bezafibrate may be useful in the treatment of high Lp(a) levels in heart transplant patients.
Referência(s)